Currently, only an estimated one in three patients with opioid use disorder receive any treatment for their condition due to varying health care access issues. Considering this significant gap, we invite you to register for an APhA Pulse on Practice & Policy Open Forum in collaboration with the National Association of Boards of Pharmacy, the National Alliance of State Pharmacy Associations, and NCPA. It all happens tomorrow, so don’t delay in registering. We will delve into the critical topic of “Medications for Opioid Use Disorder Access: Challenges and Opportunities for Pharmacy.” Join us to explore the legal and regulatory developments impacting the prescribing and dispensing of buprenorphine (especially now that the Mainstreaming Addiction Treatment and Medication Access and Training Expansion Acts are law).
NCPA
